Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Carlo C Maley"'
Autor:
Stefania E Kapsetaki, Angelo Fortunato, Zachary Compton, Shawn M Rupp, Zaid Nour, Skyelyn Riggs-Davis, Dylan Stephenson, Elizabeth G Duke, Amy M Boddy, Tara M Harrison, Carlo C Maley, Athena Aktipis
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0287901 (2023)
Chimerism is a widespread phenomenon across the tree of life. It is defined as a multicellular organism composed of cells from other genetically distinct entities. This ability to 'tolerate' non-self cells may be linked to susceptibility to diseases
Externí odkaz:
https://doaj.org/article/25870cd70dd244b2b5291cd0f79717df
Publikováno v:
PLoS Biology, Vol 19, Iss 11, p e3001471 (2021)
Trichoplax adhaerens is the simplest multicellular animal with tissue differentiation and somatic cell turnover. Like all other multicellular organisms, it should be vulnerable to cancer, yet there have been no reports of cancer in T. adhaerens or an
Externí odkaz:
https://doaj.org/article/e273c44ecc3d49498c4b65d29ad88ab3
Publikováno v:
PLoS Computational Biology, Vol 12, Iss 4, p e1004413 (2016)
When multiple samples are taken from the neoplastic tissues of a single patient, it is natural to compare their mutation content. This is often done by bulk genotyping of whole biopsies, but the chance that a mutation will be detected in bulk genotyp
Externí odkaz:
https://doaj.org/article/0d2f21bcfc1c4e3584056c5c1b175035
Autor:
Rumen L Kostadinov, Mary K Kuhner, Xiaohong Li, Carissa A Sanchez, Patricia C Galipeau, Thomas G Paulson, Cassandra L Sather, Amitabh Srivastava, Robert D Odze, Patricia L Blount, Thomas L Vaughan, Brian J Reid, Carlo C Maley
Publikováno v:
PLoS Genetics, Vol 9, Iss 6, p e1003553 (2013)
Cancer is considered an outcome of decades-long clonal evolution fueled by acquisition of somatic genomic abnormalities (SGAs). Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce cancer risk, including risk of progression from B
Externí odkaz:
https://doaj.org/article/50cc59ac550640b9badd6fb2ddfa1851
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e17933 (2011)
Metastasis represents one of the most clinically important transitions in neoplastic progression. The evolution of metastasis is a puzzle because a metastatic clone is at a disadvantage in competition for space and resources with non-metastatic clone
Externí odkaz:
https://doaj.org/article/59e7f2fc13154b7e974a5cbb615ff2e7
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26100 (2011)
Cancer therapy selects for cancer cells resistant to treatment, a process that is fundamentally evolutionary. To what extent, however, is the evolutionary perspective employed in research on therapeutic resistance and relapse? We analyzed 6,228 paper
Externí odkaz:
https://doaj.org/article/97f9579d700e4a27ad3c04c24df48d80
Publikováno v:
PLoS Computational Biology, Vol 3, Iss 12, p e250 (2007)
Cell differentiation in multicellular organisms has the obvious function during development of creating new cell types. However, in long-lived organisms with extensive cell turnover, cell differentiation often continues after new cell types are no lo
Externí odkaz:
https://doaj.org/article/e92bc3900cc9476091d166f2981968c2
Autor:
Patricia C Galipeau, Xiaohong Li, Patricia L Blount, Carlo C Maley, Carissa A Sanchez, Robert D Odze, Kamran Ayub, Peter S Rabinovitch, Thomas L Vaughan, Brian J Reid
Publikováno v:
PLoS Medicine, Vol 4, Iss 2, p e67 (2007)
BackgroundSomatic genetic CDKN2A, TP53, and DNA content abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma (EA) and Barrett's esophagus (BE), conditions for which aspirin and other nonsteroidal an
Externí odkaz:
https://doaj.org/article/7839ab16f1074de3b8ecbd0d4378ed3e
Autor:
Jens Luebeck, Alvin Wei Tian Ng, Patricia C. Galipeau, Xiaohong Li, Carissa A. Sanchez, Annalise C. Katz-Summercorn, Hoon Kim, Sriganesh Jammula, Yudou He, Scott M. Lippman, Roel G. W. Verhaak, Carlo C. Maley, Ludmil B. Alexandrov, Brian J. Reid, Rebecca C. Fitzgerald, Thomas G. Paulson, Howard Y. Chang, Sihan Wu, Vineet Bafna, Paul S. Mischel
Publikováno v:
Luebeck, J, Ng, A W T, Galipeau, P C, Li, X, Sanchez, C A, Katz-Summercorn, A C, Kim, H, Jammula, S, He, Y, Lippman, S M, Verhaak, R G W, Maley, C C, Alexandrov, L B, Reid, B J, Fitzgerald, R C, Paulson, T G, Chang, H Y, Wu, S, Bafna, V & Mischel, P S 2023, ' Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus ', Nature, vol. 616, no. 7958, pp. 798-805 . https://doi.org/10.1038/s41586-023-05937-5
Nature, 616(7958), 798-805. Nature Publishing Group
Nature, 616(7958), 798-805. Nature Publishing Group
Oncogene amplification on extrachromosomal DNA (ecDNA) drives the evolution of tumours and their resistance to treatment, and is associated with poor outcomes for patients with cancer1–6. At present, it is unclear whether ecDNA is a later manifesta
Adaptive therapy, as per the dose modulation, dose-skipping, or intermittent treatment protocol works well for treatment using a single cytotoxic drug, under a wide range of scenarios and parameter settings. In contrast, adaptive therapy works well o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b9a0f33894ef200480f431e7f027732
https://doi.org/10.1101/2023.05.14.540580
https://doi.org/10.1101/2023.05.14.540580